Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.

The phase 2 study – reported at the Conference on Retroviruses and Opportunistic Infections (CROI) in Denver, Colorado – looked at the combination of MSD’s experimental long-acting reverse ...

Following an initial announcement of positive results last year, detailed data from the two trials has been presented at the annual Conference on Retroviruses and Opportunistic Infections (CROI).

Here is some background information about stem cells. Scientists believe that stem cell research can be used to treat medical conditions including Parkinson’s disease, spinal cord injury, stroke, ...

The Global Fund program enhances training for local health workers, and provides antiretroviral treatment (ART), treatment for opportunistic infections, VCT, condom promotion, and social support.

In 2021, approval of cabotegravir (Apretude) as the first long-acting PrEP option provided patients an option to move from ...

The development of penicillin and its efficacy in the treatment of syphilis transformed syphilis management for many with and at risk for infection. However, problems such as beta-lactam allergies ...

The complex retroviruses, such as HIV, encode additional trans-regulating factors or contain cis-regulating elements, thereby influencing the type and amount of transcribed RNA. The whole viral ...

Infectious Disease News - Find the latest infectious disease news articles, videos, blogs, books, Continuing Medical Education (CME), meeting coverage, and journal articles.

Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.